Business Wire

Fast Vote Count Surprises and Delights Argentina

28.10.2019 21:42:00 EET | Business Wire | Press release

Share

Argentina processed election results with record-breaking speed during its general elections thanks to the new system implemented in partnership with technology company Smartmatic. The vote was held on October 27.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191028005666/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Telegram processing rates on election night, 2015 vs. 2019. (Photo: Business Wire)

Only three hours after voting ended, 70.48% of the tallying reports (called “telegrams” in Argentina) had been digitized, securely transmitted and uploaded into the system. By midnight, 96.08% of telegrams were processed.

Election observers representing the political parties closely monitored the entire process. The high level of transparency and speed with which the results were processed and published allowed the main candidates to publicly accept the outcomes shortly after results were announced.

“We are honored to have supported Argentine authorities for this important election by deploying Smartmatic’s unmatched technology. We were able to facilitate fast, accurate results that gave peace of mind to political parties and the country in general,” said Antonio Mugica, CEO of Smartmatic.

According to information released by election authorities, voter participation exceeded 80%. Voters chose among four candidates for head of government and six formulas for president and vice president. In eight provinces, 72 candidates vied for senate seats and 595 candidates competed to become deputies at the national level.

Smartmatic provided secure technology both for the digitation and transmission of telegrams, and for the consolidation and publication of results. Just as in the primaries held in August, telegrams were transmitted directly from over 10,000 voting centers to two consolidation centers. Approximately 1,700 operators at the consolidation centers transcribed and loaded into the system the information contained in the telegrams.

"Because of the speed and accuracy with which results were published, misinformation about the technology that had been widely distributed across social media and other news outlets fell flat and was easily discredited. Argentines today welcomed the innovations introduced by the authorities that make elections more efficient and more transparent," added Mugica.

Smartmatic participated in Argentina’s 2019 election cycle after winning two public bids in which international election technology companies competed.

It is anticipated that, as in the primaries, the provisional results will be an accurate reflection of the final vote count. In August, the difference between the provisional and final results was less than 1% in each of the Argentine provinces.

About Smartmatic

Smartmatic specializes in the design and deployment of election system technologies. As the global leader in providing secure, transparent, verifiable voting systems, Smartmatic is setting the standard for election integrity worldwide including encrypted results transmission, paper ballot back-up, extensive auditing and the first use of blockchain technology to secure online voting. Additional information about Smartmatic can be found at: www.smartmatic.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Smartmatic
Mrs. Samira Saba, +1-561-862-0747
Marketing and Communications Director
Communications@smartmatic.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Organon to Present New Research on Access and Value at ISPOR 202615.5.2026 14:30:00 EEST | Press release

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, will present data across women’s health, biosimilars, dermatology, and neurology at ISPOR 2026, the leading global scientific conference hosted by the International Society for Pharmacoeconomics and Outcomes Research. The conference, focused on health economics and outcomes research, will take place May 17-20, 2026, in Philadelphia, Pennsylvania. Across 8 accepted abstracts, the data reflect Organon’s commitment to generating real-world evidence—rooted in lived experiences—that can help inform healthcare decision-making and improve health outcomes across a range of therapeutic areas. “Health economics and outcomes research is critical to ensuring the right treatments reach patients and that health systems can sustain this approach over time,” said Juan Camilo Arjona Ferreira, MD, Head of R&D and Chief Medical Officer at Organon. “At ISPOR 2026, Organon

SES Announces Extraordinary General Meeting of Shareholders15.5.2026 09:30:00 EEST | Press release

SES: Société Anonyme RCS Luxembourg B 81267 Notice is hereby given of the Extraordinary General Meeting of SES, Société Anonyme, to be held at the Company's registered office at Château de Betzdorf, L-6815 Betzdorf (the "Company"), Luxembourg, on Wednesday 17 June 2026 at 3:00 p.m. CET AGENDA Attendance list, quorum and adoption of the agenda Nomination of a secretary and of two scrutineers Cancellation of shares purchased in connection with the buy-back programme of 2 November 2023, as amended on 2 May 2024, in accordance therewith and pursuant thereto - Reduction of the share capital in accordance with article 450-5 of the law of 10 August 1915 on commercial companies, as amended, by forty-four million nine hundred ten thousand seven hundred eighty euro (EUR 44,910,780) through the cancellation of thirty-five million nine hundred and twenty-eight thousand six hundred and twenty-four (35,928,624) shares divided into (i) twenty-three million nine hundred and fifty-two thousand four hun

Experian Partners With ServiceNow to Scale Trusted Decisioning to Agentic AI15.5.2026 09:00:00 EEST | Press release

Experian, the global data and technology company, and ServiceNow (NYSE: NOW), the AI control tower for business reinvention, today unveil a new global multi-year partnership which harnesses the power of autonomous AI agents across platforms, helping businesses make faster and smarter decisions at scale. Through this partnership, autonomous AI agents can gain the ability to act faster, and more consistently, starting with employee onboarding, third-party risk management and model life cycle governance use cases. A major challenge for global organisations adopting agentic AI is achieving scale, with deployments often constrained by a lack of trusted data. In fact, industry research shows that data limitations are the primary barrier for eight in ten organisations. By connecting trusted intelligence directly into enterprise workflows, this partnership enables agentic AI to scale well beyond pilot deployments. With the Experian Ascend Platform natively connected to the ServiceNow AI Platfo

Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― Published in The Lancet15.5.2026 04:00:00 EEST | Press release

Meiji Seika Pharma Co., Ltd. (headquartered in Tokyo; President and Representative Director: Toshiaki Nagasato) today announced that the results of the Integral-1 study, one of two global Phase III clinical trials evaluating the efficacy and safety of its novel β-lactamase inhibitor nacubactam (development code: OP0595), have been published in The Lancet. The article is entitled “---Efficacy and safety of cefepime–nacubactam and aztreonam–nacubactam compared with imipenem–cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trial” (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00596-9/fulltext) Integral-1 is a global, double-blind, randomized Phase III trial (jRCT2031230075) in patients with complicated urinary tract infection or acute uncomplicated pyelonephritis that compared the efficacy and safety of nacubactam co-administered with either cefepime or aztreonam versus imipenem-c

Xsolla and Skich Announce Strategic Partnership to Bring Merchant of Record Payments to an Alternative Mobile Game Marketplace14.5.2026 19:00:00 EEST | Press release

Xsolla, a leading global video game commerce company, today announced a strategic partnership with Skich, an alternative mobile game marketplace operating on iOS in the EU under Apple's Digital Markets Act provisions and on Android globally. Under the agreement, Xsolla will serve as Merchant of Record for in-app purchases and paid game sales distributed through the Skich Store. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514867730/en/ Graphic: Xsolla Skich serves as an alternative to traditional mobile storefronts, offering developers a way to reach players outside platform-controlled distribution channels. The partnership with Xsolla enables Skich to offer a fully compliant payment and commerce layer, with Xsolla managing payment processing, tax collection, refunds, and regulatory compliance on behalf of developers, removing a significant operational and legal barrier for studios looking to distribute through alternat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye